| The synergistic effects of ω-3 fatty acids and nano-curcumin supplementation on tumor necrosis factor (TNF)-α gene expression and serum level in migraine patients M Abdolahi, A Tafakhori, M Togha, AA Okhovat, F Siassi, MR Eshraghian, ... Immunogenetics 69, 371-378, 2017 | 104 | 2017 |
| Independent association between air pollutants and vitamin D deficiency in young children in Isfahan, Iran R Kelishadi, R Moeini, P Poursafa, S Farajian, H Yousefy, ... Paediatrics and international child health 34 (1), 50-55, 2014 | 81 | 2014 |
| Associations between adherence to dietary approaches to stop hypertension (DASH) diet and migraine headache severity and duration among women A Mirzababaei, F Khorsha, M Togha, MS Yekaninejad, AA Okhovat, ... Nutritional neuroscience 23 (5), 335-342, 2020 | 68 | 2020 |
| Modified Atkins diet in adult with refractory epilepsy: a controlled randomized clinical trial M Zare, AA Okhovat, A Esmaillzadeh, J Mehvari, MR Najafi, M Saadatnia Iranian journal of neurology 16 (2), 72, 2017 | 60 | 2017 |
| Molecular mechanisms of omega-3 fatty acids in the migraine headache N Soveyd, M Abdolahi, S Bitarafan, A Tafakhori, P Sarraf, M Togha, ... Iranian journal of neurology 16 (4), 210, 2017 | 37 | 2017 |
| Myasthenia gravis associated with novel coronavirus 2019 infection: A report of three cases N Karimi, AA Okhovat, B Ziaadini, BH Ashtiani, S Nafissi, F Fatehi Clinical neurology and neurosurgery 208, 106834, 2021 | 31 | 2021 |
| Guillain-Barre syndrome and COVID-19 vaccine: a report of nine patients N Karimi, R Boostani, F Fatehi, A Panahi, AA Okhovat, B Ziaadini, K Basiri, ... Basic and Clinical Neuroscience 12 (5), 703, 2021 | 25 | 2021 |
| Epidemiology and clinical features of Guillain-Barre syndrome in Isfahan, Iran B Ansari, K Basiri, Y Derakhshan, F Kadkhodaei, AA Okhovat Advanced Biomedical Research 7 (1), 87, 2018 | 25 | 2018 |
| Life-threatening misdiagnosis of bulbar onset myasthenia gravis as a motor neuron disease: How much can one rely on exaggerated deep tendon reflexes K Basiri, B Ansari, AA Okhovat Advanced biomedical research 4 (1), 58, 2015 | 23 | 2015 |
| Supratentorial cortical ependymoma: an unusual presentation of a rare tumor MR Mohaghegh, A Chitsaz, AA Okhovat, EB Pour Advanced biomedical research 4 (1), 72, 2015 | 11 | 2015 |
| BVVL/FL: features caused by SLC52A3 mutations; WDFY4 and TNFSF13B may be novel causative genes M Khani, H Shamshiri, H Taheri, J Hardy, JT Bras, S Carmona, ... Neurobiology of Aging 99, 102. e1-102. e10, 2021 | 8 | 2021 |
| Clinical features and outcomes of patients with myasthenia gravis affected by COVID-19: a single-center study N Karimi, F Fatehi, AA Okhovat, S Abdi, F Sinaei, H Sikaroodi, Z Vahabi, ... Clinical Neurology and Neurosurgery 222, 107441, 2022 | 7 | 2022 |
| Neuromuscular manifestations of lead poisoning in opium and herbal users in Iran AA Okhovat, B Ansari, K Basiri, F Fatehi Revue neurologique 176 (10), 856-863, 2020 | 7 | 2020 |
| Adult‐onset very‐long‐chain acyl‐CoA dehydrogenase deficiency (VLCADD) F Fatehi, AA Okhovat, Y Nilipour, M Mroczek, V Straub, A Töpf, A Palibrk, ... European journal of neurology 27 (11), 2257-2266, 2020 | 7 | 2020 |
| Application of muscle ultrasound for the evaluation of patients with amyotrophic lateral sclerosis: An observational cross‐sectional study S Rajabkhah, K Moradi, AA Okhovat, N Van Alfen, D Fathi, ... Muscle & Nerve 62 (4), 516-521, 2020 | 7 | 2020 |
| Thigh and Leg Muscle MRI Findings in GNE Myopathy F Fatehi, S Advani, AA Okhovat, B Ziaadini, H Shamshiri, S Nafissi Journal of Neuromuscular Diseases 8 (4), 735-742, 2021 | 6 | 2021 |
| Sporadic late-onset nemaline myopathy with monoclonal gammopathy of undetermined significance: report of four patients AA Okhovat, Y Nilipour, R Boostani, F Vahabizad, S Najmi, S Nafissi, ... Neuromuscular Disorders 31 (1), 29-34, 2021 | 6 | 2021 |
| Watershed Infarct in Beta‐Thalassemia Major Patient B Ansari, M Saadatnia, A Asghar Okhovat Case Reports in Neurological Medicine 2017 (1), 2736402, 2017 | 6 | 2017 |
| The value of MUNIX as an objective electrophysiological biomarker of disease progression in chronic inflammatory demyelinating polyneuropathy AA Okhovat, S Advani, B Ziaadini, A Panahi, S Salehizadeh, S Nafissi, ... Muscle & Nerve 65 (4), 433-439, 2022 | 5 | 2022 |
| Retrospective analysis of response to rituximab in chronic inflammatory demyelinating polyneuropathy refractory to first‐line therapy F Fatehi, AA Okhovat, A Panahi, B Ziaaddini, YA Rajabally, S Nafissi Journal of the Peripheral Nervous System 26 (4), 469-474, 2021 | 4 | 2021 |
